Page 1 of Clinical Trials for Drug AMG 386, 19 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal Function
Last Updated: September 29, 2011
Condition(s): Advanced Solid Tumors; Kidney Disease; Renal Impairment
2
Recruiting
I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Last Updated: December 21, 2011
Condition(s): Breast Neoplasms; Breast Cancer; Breast Tumors
3
Recruiting
Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer
Last Updated: November 29, 2010
Condition(s): Metastatic Colorectal Cancer
4
Active, not recruiting
Phase 2 Study of AMG 386 Plus Paclitaxel With or Without Bevacizumab as First Line Therapy in Her2-Negative Breast Cancer Patients
Last Updated: September 15, 2011
Condition(s): Locally Recurrent and Metastatic Breast Cancer
5
Active, not recruiting
To Evaluate the Safety, Tolerability and Pharmacokinetics of AMG 386 When Used in Combination With AMG 706, Bevacizumab, Sorafenib, or Sunitinib.
Last Updated: January 20, 2011
Condition(s): Advanced Solid Tumors
6
Recruiting
TRINOVA-1: A Study of AMG 386 or Placebo, in Combination With Weekly Paclitaxel Chemotherapy, as Treatment for Ovarian Cancer, Primary Peritoneal Cancer and Fallopian Tube Cancer
Last Updated: January 18, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer
7
Active, not recruiting
Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma
Last Updated: January 20, 2011
Condition(s): Gastrointestinal Cancer
8
Suspended
TRINOVA-2: TRial IN OVArian Cancer-2
Last Updated: January 30, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer
9
Recruiting
Safety Study of AMG 386 to Treat HER2-positive Locally Recurrent or Metastatic Breast Cancer
Last Updated: September 22, 2011
Condition(s): Breast Cancer; Breast Neoplasms; Breast Tumors; Cancer; Locally Recurrent and Metastatic Breast Cancer; Metastases; Metastatic Cancer; Oncology; Solid Tumors; Tumors
10
Active, not recruiting
AMG 386 Phase 2 Open-Label Renal Cell Carcinoma (RCC) Study 1st Line or After Cytokine Failure in Combination With Sunitinib
Last Updated: February 17, 2011
Condition(s): Advanced Renal Cell Carcinoma
11
Recruiting
TRINOVA-3: A Study of AMG 386 or AMG 386 Placebo in Combination With Paclitaxel and Carboplatin to Treat Ovarian Cancer
Last Updated: January 18, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cancer
12
Active, not recruiting
Phase 2, AMG 386 (20060342) in Combination With Paclitaxel for Subjects With Advanced Recurrent Epithelial Ovarian or Primary Peritoneal Cancer
Last Updated: January 20, 2011
Condition(s): Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer
13
Active, not recruiting
A Multi-Center Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With High-Risk Stage I and Stages II-IV Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers
Last Updated: January 17, 2012
Condition(s): Carcinoma; Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cancer
14
Recruiting
A Phase 1b Study of AMG 386 in Combination With Either Pegylated Liposomal Doxorubicin or Topotecan in Subjects With Advanced Recurrent Epithelial Ovarian Cancer
Last Updated: September 8, 2011
Condition(s): Cancer; Carcinoma; Fallopian Tube Cancer; Gynecological Malignancies; Metastases; Oncology; Ovarian Cancer; Solid Tumors; Tumors
15
Active, not recruiting
A Study of the Effectiveness and Safety of AMG 386 and Sorafenib to Treat Advanced or Inoperable Hepatocellular Cancer
Last Updated: September 22, 2011
Condition(s): Advanced or Inoperable Hepatocellular Carcinoma
16
Recruiting
Amgen 386 for Recurrent Glioblastoma
Last Updated: February 3, 2011
Condition(s): Glioblastoma Multiforme
17
Active, not recruiting
AMG 386, 20060159 Phase 2, RCC 1st Line in Combination With Sorafenib
Last Updated: January 20, 2011
Condition(s): Advanced Renal Cell Carcinoma
18
Active, not recruiting
A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma
Last Updated: July 21, 2011
Condition(s): Cancer; Carcinoma; Colon Cancer; Colorectal Cancer; Gastrointestinal Cancer; Metastases; Metastatic Cancer; Metastatic Colorectal Cancer; Oncology; Rectal Cancer
19
Completed
Study Evaluating AMG 386 in Adult Patients With Advanced Solid Tumors
Last Updated: August 19, 2010
Condition(s): Tumors

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+AMG+386

Page 1 of Clinical Trials for Drug AMG 386, 19 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About